Abstract:Pyroptosis, a type of regulated cell death, has been shown to be immunogenic in quite a few studies. Pyroptosis has been observed since 1986 and was found to be mediated by GSDM family proteins until recently. Gasdermines (GSDMs) are a group of intracellular proteins that mediates cell pyroptosis. Although GSDMs are expressed in inactive forms, some proteolytic enzymes can activate them. The N-terminus of activated GSDMs perforate the plasma membrane, resulting in cell lysis. Pyroptosis is a double-edged sword that is closely related to the tumor immune microenvironment. Pro-inflammatory molecules and DAMPs will be quickly and effectively released into the microenvironment from the pyroptotic cells, and trigger inflammation and immune response, while these immune responses are not always positive. Inductions of pyroptotic cell death have been shown to promote anti-tumor immunity and improve the efficacy of immune checkpoint inhibitors, which involves the cytotoxic effects of effector T lymphocytes, or reprogramming of the tumor microenvironment to an immunostimulatory state. In this review, we not only summarize the mechanisms of different types of pyroptosis and the key molecules that promote inflammatory and immune response during pyroptosis, but also compare its common features with apoptosis. In addition, we discuss the potential positive and negative factors to cancer therapy during pyroptosis. Although our understanding of pyroptosis in cancer is growing, many mechanisms remain unclear: how pyroptosis activates the immune system, how pyroptosis is regulated, and how pyroptosis can be harnessed therapeutically to improve cancer immunotherapy or to reduce therapy related toxicity. We hope this review will help further understanding the role of pyroptosis in tumor microenvironment and cancer immune therapy, promoting the improvement of cancer therapy strategies.

Pyroptosis, inflammasome, and gasdermins in tumor immunity

Gasdermins: a dual role in pyroptosis and tumor immunity

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment

Gasdermin-mediated Pyroptosis Confers Anticancer Immunity

Role of pyroptosis in inflammation and cancer

Molecular mechanisms of pyroptosis and its role in anti-tumor immunity

Biological Functions of Gasdermins in Cancer: From Molecular Mechanisms to Therapeutic Potential

Gasdermins and Cancers.

The Role of Cell Pyroptosis Mediated by GSDMs in Antitumor Immunity

The role of pyroptosis in cancer: key components and therapeutic potential

Pyroptosis, metabolism, and tumor immune microenvironment

Research Progress of the Relationship Between Pyroptosis and Disease

Gasdermin D in pyroptosis

Pyroptosis in Cancer: Friend or Foe?

The gasdermin family: emerging therapeutic targets in diseases

Induction of Pyroptosis and Its Implications in Cancer Management

Pyroptosis: A New Frontier in Cancer

Molecular mechanism of pyroptosis and inflammasome activation

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

Pyroptosis, a new bridge to tumor immunity